Share Prices & Company Research

Stockbroking

Integrated Diagnostics Holdings Plc

Current Price 34.50p Bid 33.00p Ask 36.00p Change -4.17%
Last Updated: 06/05/2025 10:09. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Financial Highlights Year Ended 31/12/2019

Revenue
£2,226.49m
Operating Profit/Loss
£790.84m
Dividend yield (%)
n/a
Total dividend for year
£n/a
Dividend cover
n/a
P/E Ratio
18.40

Key Personnel

Prof. Dr. Hend El Sherbini
Group Chief Executive
Mr James Patrick Nolan
Independent Non-Executive Director
Lord Anthony St John
Non-Executive Chairman
Mr Dan Olsson
Non-Executive Director
Mr Hussein Choucri
Non-Executive Director
Mr Richard Henry Phillips
Non-Executive Director

Stock Details

EPIC
IDHCL
ISIN
JE00BV9H9G76
Shares in Issue
0.00m
Market cap
£0.00m

Analyst Views (3)

Strong Buy
 
0%
Buy
 
66.67%
Hold
 
33.33%
Sell
 
0%
Strong Sell
 
0%
This information is provided by Web Financial Group (UK) Limited. It is subject to change without notice and doesn't reflect the views held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
34.50p
Bid Price
33.00p
Ask Price
36.00p
Volume
0
Change Today
-1.50p
% Change Today
-4.17%
Open
36.00p
Previous Close
36.00p
Intraday High
36.00p
Intraday Low
32.20p
52 Week High
51.70p
52 Week Low
27.50p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart


Cboe Global Markets® is a registered trade mark of Cboe Global Markets, Inc., a company incorporated in the United States of America with registered address at 400 South LaSalle Street, Chicago, IL 60605, USA. Cboe shall own any and all rights including without limitation Intellectual Property rights and any and all goodwill arising directly or indirectly out of the Recipient’s use of the “Cboe Global Markets®”, “Cboe®” and “Bats®”” trademarks. Neither Cboe nor its licensors accept any liability for any errors or omissions in the Cboe Europe Indices or underlying data. No further distribution of Cboe Europe data is permitted without Cboe’s express written consent.

The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.